Common Contracts
2 similar Form of Security Agreement contracts by Neuraxis, INC, Vitro Biopharma, Inc.
FORM OF SECURITY AGREEMENTForm of Security Agreement • November 22nd, 2023 • Vitro Biopharma, Inc. • Biological products, (no disgnostic substances)
This SECURITY AGREEMENT, dated as of November 16, 2023 (this “Agreement”), is among Vitro Biopharma, Inc., a Nevada corporation ( “Debtor”), on the one hand, and the holder(s) of the Company’s 20% original issue discount senior secured convertible notes in the aggregate original principal amount of up to $3,000,000.00 (collectively, the “Notes”) signatory hereto, their endorsees, transferees and assigns (each holder a “Secured Party,” and collectively, the “Secured Parties”), on the other. Each of the Company and the Secured Parties are a “party” to this Agreement, and one or more of them are the “parties” hereto as the context may require.
FORM OF SECURITY AGREEMENTForm of Security Agreement • June 1st, 2023 • Neuraxis, INC • Electromedical & electrotherapeutic apparatus
This SECURITY AGREEMENT, dated as of February ___, 2023 (this “Agreement”), is among Neuraxis, Inc., a Delaware corporation (the “Company” or “Debtor”) and the holder(s) of the Company’s 10% original issue discount senior secured convertible notes in the aggregate original principal amount of up to $6,666,666.67 (collectively, the “Notes”) signatory hereto, their endorsees, transferees and assigns (each holder a “Secured Party,” and collectively, the “Secured Parties”). Each of the Company, and the Secured Parties are a “party” to this Agreement, and one or more of them are the “parties” hereto as the context may require.
